← Back to headlines
Novartis Cholesterol Trial Fails to Meet Primary Endpoints
The pharmaceutical company reports that its closely monitored clinical study for a new cholesterol treatment did not achieve its targeted results.
4 Sept, 23:55 — 4 Sept, 23:55
Sources
Showing 1 of 1 sources
